Recently, consensus statements on post-menopausal flushing have been published, and novel therapies devised for the treatment of carcinoid-induced flushing. In our experience, its presence may cause on-going uncertainty in the physician and continuing anxiety in the patient. ![]() Flushing is also included in the manifestations of the carcinoid syndrome, occurring in 20–30% of patients with midgut neuroendocrine tumours (NETs).įlushing is not an uncommon presenting symptom to endocrinologists, but as such is generally not well covered in endocrine texts. Around 80% ( 1) of post-menopausal women experience hot flushes, and a similar syndrome is seen in more than 65% of men with prostatic cancer during treatment with medical or surgical castration ( 2), being the most common complaint reported by men undergoing androgen suppression treatment ( 3). ![]() Flushing characteristically occurs in episodic attacks contrasting with the persistent erythema of photosensitivity, erythema multiforme or sunburn, and in carcinoid syndrome, flushing may result in telangiectasias.Įpidemiologically, the data are difficult to report due to the large variety of conditions and drugs related to flushing. Flushing can be defined as a sensation of warmth accompanied by erythema that most commonly occurs on the face, but may also involve the neck, ears, chest, epigastrium, arms or other areas.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |